Forte Biosciences (FBRX) IV elevated into data

Forte Biosciences (NASDAQ: FBRX) September call option implied volatility is at 410, October is at 310; compared to its 52-week range of 87 to 365 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis. Call put ratio 1 call to 1.1 puts.

You May Also Be Interested In

• Oracle (ORCL) call put ratio 2.4 calls to 1 put with a focus on October 165 calls
• ACV (ACVA) call put ratio 43 calls to 1 put into Copart (CPRT) into acquire
• ViaSat (VSAT) 3400 contracts of Dember 110 calls trade, share price up 2.3%